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Evidence for a LOS and a capsular 
polysaccharide in Capnocytophaga 
canimorsus
Francesco Renzi1, Simon J. Ittig2, Irina Sadovskaya3, Estelle Hess1, Frederic Lauber1, 
Melanie Dol1, Hwain Shin2, Manuela Mally2, Chantal Fiechter2, Ursula Sauder4, 
Mohamed Chami4 & Guy R. Cornelis1
Capnocytophaga canimorsus is a dog’s and cat’s oral commensal which can cause fatal human infections 
upon bites or scratches. Infections mainly start with flu-like symptoms but can rapidly evolve in fatal 
septicaemia with a mortality as high as 40%. Here we present the discovery of a polysaccharide capsule 
(CPS) at the surface of C. canimorsus 5 (Cc5), a strain isolated from a fulminant septicaemia. We provide 
genetic and chemical data showing that this capsule is related to the lipooligosaccharide (LOS) and 
probably composed of the same polysaccharide units. A CPS was also found in nine out of nine other 
strains of C. canimorsus. In addition, the genomes of three of these strains, sequenced previously, 
contain genes similar to those encoding CPS biosynthesis in Cc5. Thus, the presence of a CPS is likely 
to be a common property of C. canimorsus. The CPS and not the LOS confers protection against the 
bactericidal effect of human serum and phagocytosis by macrophages. An antiserum raised against 
the capsule increased the killing of C. canimorsus by human serum thus showing that anti-capsule 
antibodies have a protective role. These findings provide a new major element in the understanding of 
the pathogenesis of C. canimorsus.
Capnocytophaga canimorsus (formerly Centers for Disease Control group DF-2) are capnophilic Gram-negative 
bacteria that belong to the family of Flavobacteriaceae in the phylum Bacteroidetes. C. canimorsus is found in the 
normal oral flora of dogs and cats. Since its discovery in 1976, it is regularly isolated from severe human infections 
following contact with a dog or a cat1–3. The incidence of the infection has been estimated to 0.5 and 0.63 case/
million inhabitants per year in Denmark and the Netherlands respectively4,5. However, a recent study carried out 
in Helsinki concluded that the incidence was of 4.1 cases/million inhabitants per year6 thus showing that the dis-
ease is more frequent than previously thought and that it is underestimated probably because of under-diagnosis 
mainly due to the fastidious growth of these bacteria in culture. C. canimorsus infections generally begin with 
flu symptoms and evolve in a few days into fulminant septicaemia and peripheral gangrene with mortality as 
high as 40%1,4,7–9. Splenectomy, alcohol abuse and immunosuppression have been associated with a number of 
cases, but more than 40% of the patients have no obvious risk factor10,11. Recent observations help understand-
ing the infectiveness of C. canimorsus for humans. C. canimorsus manifest some resistance to phagocytosis by 
human polymorphonuclear leukocytes and detection by macrophages12,13, which results in a lack of release of 
pro-inflammatory cytokines14. Like many Gram-negative pathogens, C. canimorsus resist the bactericidal activity 
of 10% human or rabbit serum13,15 but they are nevertheless killed by undiluted fresh serum or blood16,17. In addi-
tion to the passive evasion from innate immunity, some strains are able to block the killing of E. coli phagocytosed 
by macrophages12,18 and to block the onset of pro-inflammatory signaling induced by an E. coli LPS stimulus14. 
C. canimorsus also have the unusual property to deglycosylate mammalian proteins, including IgG, IgM and 
surface glycoproteins from phagocytes19–22.
Gram-negative bacteria have a complex set of surface polysaccharides, which contribute to pathogenicity 
as well as commensalism23–32. These include the lipopolysaccharide (LPS) as well as capsular polysaccharides 
(CPS) or exopolysaccharides (EPS)33. The LPS, a major component of the outer membrane and one of the most 
pro-inflammatory bacterial compounds, consists of three regions: lipid A, which is generally responsible for 
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triggering inflammation34,35, the core oligosaccharide, and the O-antigen. The C. canimorsus LPS is 100 fold less 
endotoxic than the highly immunogenic E. coli LPS14,36. Surprisingly, the lipid A alone, which is penta-acylated, 
lacking the 4′ phosphate and harboring a 1 phosphoethanolamine (P-Etn) at 2-amino-2-deoxy-D-glucose (GlcN) 
is almost not pro-inflammatory at all and thus the low endotoxic activity observed is conferred by the core oli-
gosaccharide36. The LPS O-antigen of Gram-negative bacteria greatly varies between and within species, provid-
ing the main basis for serotyping. It can be a virulence factor contributing to serum resistance27,28,30–32,37–42 and 
O-antigen deficient strains of different bacteria have generally reduced virulence30,31. The O-antigen is synthe-
sized independently of the lipid A-core35 and generally consists of several repeats of an identical oligosaccharide 
called the O-unit. Three pathways have been described for LPS biosynthesis and translocation, which essentially 
differ by their export mechanism. According to the main proteins involved, they are called Wzy-dependent, 
ABC-transporter dependent and synthase dependent43. Outside the LPS, many Gram-negative bacteria, includ-
ing E. coli, have a capsular structure that increases their resistance towards the innate immune system (for review 
see44). These structures have various compositions and are assembled by diverse pathways. In E. coli, on the basis 
of genetics and biochemical criteria, capsules have been divided in four main groups. The biosynthesis and assem-
bly mechanisms of capsules are closely related to those of the LPS and so group I and IV capsules are assembled 
by the Wzy-dependent pathway while group II and III capsules are assembled by ABC transporter-dependent 
pathways (for review see33). In the Wzy-dependent pathway the LPS O-chain is composed of repeating O-units 
that are polymerized by the activity of the Wzy polymerase43. The large structural diversity between O-antigens 
is the result of variations in the composition, sequence, and linkage of the O-units. The O-antigen repeating 
units are first assembled in the cytoplasm, linked to the lipid carrier undecaprenol phosphate (und-PP) and 
then transported across the inner membrane to the periplasm by the Wzx flippase. The und-PP-linked O-units 
are then polymerized on the periplasmic leaflet of the inner membrane by the Wzy polymerase that allows the 
formation of the complete O-chain. The O-chain is finally ligated to the core oligosaccharide by the WaaL ligase 
forming a complete LPS that is then translocated to the bacterial surface by the Lpt-system45. In group I and IV 
capsules, the O-units, assembled by the Wzx/Wzy-dependent pathway, are translocated to the bacterial surface by 
the coordinated action of the Wza, Wzb and Wzc proteins46. The Wza proteins form a channel in the outer mem-
brane allowing capsule export and the translocation is controlled by the coordinated activity of the Wzc tyrosine 
autokinase and its cognate phosphatase Wzb47,48.
The C. canimorsus lipid A and core oligosaccharide chemical structures were recently established36,49. To date, 
no data are available on the composition and structure of the C. canimorsus LPS O-antigen.
Here we show that C. canimorsus 5 possesses a lipooligosaccharide (LOS) rather than a LPS and a capsular 
polysaccharide (CPS) likely made of the same O-antigen repeating units. The CPS and not the LOS increases 
resistance to human serum, polymyxin B and phagocytosis by macrophages. Finally, antibodies raised against the 
LOS O-antigen and CPS have a protective role.
Results
C. canimorsus 5 has a high molecular weight polysaccharide related to the O-antigen. In our 
previous work we isolated a C. canimorsus 5 (Cc5) transposon mutant, named Y1C12, which was hypersensitive 
to killing by human complement and phagocytosis13. The mutation inactivated a putative glycosyltransferase 
gene suggesting that the Y1C12 mutant was affected at the level of a polysaccharide structure, likely the LPS 
O-antigen13,49. Analysis of bacterial polysaccharide structures by digesting whole bacteria with proteinase K and 
detection by western blot using both a crude anti-Cc5 serum and a Y1C12-adsorbed anti-Cc5 serum showed that 
C. canimorsus 5 has several polysaccharide structures (Fig. 1a,b and ref. 13). Two of them, a low molecular weight 
structure (band C in Fig. 1 and ref. 13) and a high molecular weight one (band E in Fig. 1) appeared to be affected 
in the Y1C12 mutant. While the low molecular weight band was shifted in size (band C* in Fig. 1a and ref. 13), 
the high molecular weight structure was completely missing in the Y1C12 mutant strain (Fig. 1a and b). Since the 
low molecular weight structure (band C), and its smaller version (band C*), could be isolated by LPS purification 
procedures with phenol-chloroform-petroleum ether36 (Fig. 1a) and labeled by tritiated palmitate (Fig. 1c and 
ref. 13), we conclude that it represents the LPS. However, the absence of a ladder-like pattern suggested that it is 
composed of a limited number of O-antigen repeat units and thus represents a lipooligosaccharide (LOS)50 rather 
than a LPS. Another structure, band D in Fig. 1a, could also be isolated by LPS purification procedures36 (Fig. 1a) 
and was labeled by tritiated palmitate (Fig. 1c) but was not affected in the Y1C12 mutant suggesting that it could 
represent an additional LOS/LPS form different from band C. In contrast, the high molecular weight structure, 
present in the wt strain but missing in the Y1C12 mutant (band E), could not be isolated by LPS purification 
methods (Fig. 1a) and was not labeled by tritiated palmitate (Fig. 1c and ref. 13) suggesting that it could represent 
a capsular polysaccharide (CPS) not linked to the lipid A-core. The absence of this putative capsule in the Y1C12 
strain together with the presence of an altered LOS, suggested that the biosynthetic pathways of the CPS and the 
O-antigen could be partially common. This view is reinforced by the fact that both the putative CPS (band E) 
and the wt LOS (band C) were recognized by the Y1C12-adsorbed antiserum (Fig. 1b). Assuming the epitope 
recognized by the Y1C12-adsorbed antiserum is the O-antigen repeating unit (or parts thereof), one could infer 
that band C corresponds to LOS and that the chemical structure of the repeating unit (or parts thereof) of the 
CPS and LOS O-antigen could be similar if not identical. The gene inactivated in mutant Y1C12 turned out to be 
Ccan_2337051, now annotated as wbuB, an N-acetylfucosamine (FucNAc) transferase, suggesting that FucNAc 
could be part of both the LOS O-antigen and the CPS.
A capsule is present at the bacterial surface. In order to visualize the C. canimorsus CPS at the bac-
terial surface we analyzed thin sections of resin embedded wt and Y1C12 mutant C. canimorsus bacteria by 
transmission electron microscopy. As shown in Fig. 1d, a thick layer was present at the bacterial surface adjacent 
to the outer membrane of wt cells while it was missing in the Y1C12 strain. This layer was also visualized by 
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cryo-electron microscopy on frozen-hydrated wt bacteria (Fig. 1e). This technique, preserving the structures 
integrity, allowed estimating the layer thickness to around 50 nm. This layer thus represents the Cc5 CPS and 
resembles the capsular polysaccharides described in Bacteroides fragilis52.
Overall, these data indicate that C. canimorsus 5 possesses a high molecular weight polysaccharidic structure related 
to the LOS O-antigen. This structure could thus be a group I or IV capsule made out of O-antigen repeating units33.
Identification of the genes encoding the capsule and the O-antigen of C. canimorsus 5. In order to 
see whether CPS and O-antigen would share the same biosynthetic pathways, we first identified the genes involved in 
the biosynthesis of the capsule and the LOS O-antigen monosaccharides. To this aim we took advantage of the trans-
poson Tn4351 library that previously allowed us to identify the Y1C12 mutant13. We isolated two other mutants (Y1D1 
and Y3A2) whose survival rate in 10% human serum was severely decreased compared to that of the wt C. canimorsus 
5 (Supplementary Fig. S1). Analysis of bacterial polysaccharide structures of Y1D1 and Y3A2 by western blot using 
both a crude anti-Cc5 serum and a Y1C12-adsorbed anti-Cc5 serum showed that both mutants, like Y1C12, lacked 
the capsular polysaccharide as well as the wt LOS band (band C and E in Fig. 2a and b). The integration sites of the 
transposon in Y1D1 and Y3A2 were mapped on the C. canimorsus 5 genome sequence51 and were found to be located 
in different genes clustered with wbuB (Y1C12)13 in one locus (Fig. 2c). This locus encodes 28 genes, whereof 23 are 
predicted to be involved in sugar synthesis, transfer or export. In Y1D1 the transposon inserted in gene wbtA (wbtA 
in F. tularensis or wbpM in P. aeruginosa), a gene required for N-acetylquinovosamine (QuiNAc) biosynthesis53–55 
(Fig. 2c and d). For Y3A2, the transposon was found in gene uge, whose product converts D-glucuronate (GlcA) into 
D-galacturonate (GalA) (Fig. 2c and d). These data thus suggest that FucNAc, QuiNAc and GalA or derivatives thereof 
are part of the C. canimorsus 5 CPS and LOS-O-antigen.
The capsule assembly is Wzx/Wzy dependent. To further clarify the relation between the capsule and 
LOS, we investigated their transport and assembly pathway. In the gene cluster previously identified (Fig. 2c) 
Ccan_23200 shows sequence similarity to Wzx, the O-antigen flippase involved in the transport of O-antigen 
units to the periplasm across the inner membrane43,56 while Ccan_23280 has sequence similarity to the O-antigen 
polymerase Wzy involved in the polymerization of the O-antigen repeating units, thus suggesting that the C. can-
imorsus 5 O-antigen and/or the CPS are synthesized by a Wzx/Wzy dependent pathway43. In order to verify this, 
we generated a Ccan_23200 (putative wzx) mutant strain and analyzed its LOS and CPS by western blot. Mutation 
of wzx turned out to be polar but could be complemented by wzx plus Ccan_23210 (Supplementary Data S1 
and Supplementary Fig. S2). Even when properly complemented, the wzx mutant was still unable to produce 
Figure 1. Y1C12 mutant shows an altered LPS and lacks a putative CPS. (a) Immunoblot analysis of 
proteinase K-treated wt Cc5 and Y1C12 mutant bacterial lysates and of LPS isolated from wt Cc5 and Y1C12 
mutant using anti-Cc5 serum. (b) Immunoblot analysis as described in (a) using Y1C12-adsorbed anti-Cc5 
serum. (c) Proteinase K-resistant structures of wt Cc5 and Y1C12 mutant that had been labeled in vivo using 
[9,10-3H] palmitic acid. Electron micrographs of thin sections (d) and frozen-hydrated (e) wt and Y1C12 
bacteria. The double arrow indicates the capsule (CPS). The scale bar is 100 nm.
www.nature.com/scientificreports/
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the LOS and the CPS suggesting that Ccan_23200 could indeed encode for the Wzx O-chain transporter 
(Supplementary Data 1 and Supplementary Fig. S2).
Deletion of the putative polymerase wzy gene (Ccan_23280) determined the disappearance of the CPS, 
significantly reduced normal LOS biosynthesis and led to the formation of low molecular weight LOS bands 
(Supplementary Fig. S2). However, the wzy mutation turned out to be polar on Ccan_23290 encoding a gly-
cosyltransferase (Supplementary Data S2 and Supplementary Fig. S2). Expression of Ccan_23290 in the wzy 
mutant restored the wt LOS profile but not the CPS (Supplementary Fig. S2), suggesting that Ccan_23280 indeed 
encodes the Wzy O-antigen polymerase that is responsible for the assembly of the CPS but not of the LOS 
O-chain. This also indicates that LOS band C represents the lipid A-core plus only one O-antigen unit. Notably, 
a second LOS band (band C#), with a higher molecular weight than band C, can be observed in the wt strain 
(Supplementary Fig. S2). This band was absent in the wzy (Ccan_23290+) strain thus indicating that it could rep-
resent a LOS with more than one O-antigen unit. Co-expression of wzy and Ccan_23290 in the wzy mutant strain 
not only restored the CPS and LOS (band C and C#) profiles but also determined the formation of an LPS-like lad-
der pattern (Supplementary Fig. S2) suggesting that over-expression of wzy determines the formation of O-chains 
of different length. This pattern allows to deduce that band C# consists of five repeated units. All together these 
data indicate that Cc5 possesses: a low molecular weight LOS (band C) composed of one O-antigen unit, a higher 
molecular weight LOS (band C#) likely composed of five O-antigen repeats and a capsular polysaccharide made 
of O-antigen units polymerized by Wzy.
The capsular polysaccharide and the O-antigen repeating units share a structural similarity. In 
order to further corroborate that Cc5 CPS and the LOS O-antigen share common elements, we attempted to iso-
late both Cc5 LOS O-antigen and CPS and to determine their chemical composition. To this aim, Cc5 bacteria 
were subjected to hot phenol extraction57. Preliminary experiments identified carbohydrate molecules in both 
aqueous and phenol phases, therefore phenol extracts were further processed without phase separation. Both 
crude extracts were treated with hot dilute AcOH and fractionated on a Sepharose S-300 gel filtration chromatog-
raphy column. Two major carbohydrate fractions, a high molecular weight (HMW) and a low molecular weight 
(LMW), were collected, in agreement with the electrophoretic profiles observed by western blot analysis. The 
HMW fraction eluted close to the void volume of the column (MW~200–300 kDa), and was more abundant in 
the aqueous phase preparation. Western blot analysis of the phenol extract showed a profile identical to that of 
the proteinase K digested bacteria, the aqueous phase being enriched with the HMW band E, the CPS. GC-MS 
analysis of this fraction showed that it contained QuiN, FucN, glucose (Glc), galactose (Gal) and galactosamine 
(GalN) (Fig. 3a). In addition, a colorimetric assay58 showed the presence of uronic acid.
The LMW fraction, presumably corresponding to the carbohydrate part of LOS bands C, C# and D, was fur-
ther fractionated on a BioGel P2 column, showing a heterogeneous profile. The major carbohydrate-positive 
fraction contained QuiN, FucN, Glc, Gal and GalN (Fig. 3b). These monosaccharides could be attributed to 
Figure 2. Identification of the Cc5 O-antigen cluster. (a) Immunoblot analysis of proteinase K-treated wt 
Cc5 and Tn4351 mutated Cc5 using anti-Cc5 serum. (b) Immunoblot analysis as described for panel (a) using 
Y1C12-adsorbed anti-Cc5 serum. (c) Genetic organization of the O-antigen cluster of Cc5. Extents, orientation 
and names of the genes are indicated. Flags indicate position and orientation of Transposon 4531 insertions.  
(d) Representation of the sugar biosynthetic pathways affected in the transposon mutants. Adapted from53.
www.nature.com/scientificreports/
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the O-antigen repeating unit. In addition, the fraction contained rhamnose (Rha), glucosamine (GlcN) and 
ribose (Rib) (Fig. 3b). Presence of GlcN and Rib could result from contaminations with lipid A and nucleic acids. 
Rhamnose was shown to be part of the LOS core oligosaccharide of C. canimorsus 549.
Altogether these data provide an additional evidence that Cc5 CPS and LOS O-antigen share common struc-
tural elements and epitopes. Furthermore, the finding of FucN, QuiN and an uronic acid is in perfect agreement 
with the annotation of the genes hit in the transposon mutants Y1C12, Y1D1 and Y3A2 (Fig. 2c and d).
Generation of a non-capsulated C. canimorsus strain. As previously mentioned, the Y1C12 strain13 
as well as all the transposon mutants affected in O-antigen and capsule synthesis were found to be more sensitive 
to the bactericidal effect of 10% human serum. Furthermore, the Y1C12 mutant was found to be also more sensi-
tive to phagocytosis by polymorphonuclear leukocytes13. We thus asked whether these phenotypes would be the 
result of altered LOS O-antigen or absence of the CPS. To discriminate the contribution of these two structural 
elements, we needed to generate a strain lacking only the CPS and another strain lacking only the LOS-O-antigen 
(rough LOS, but encapsulated).
In general, once the O-antigen units have been assembled by the Wzy polymerase, they are ligated to the lipid 
A-core by the WaaL ligase (formerly RfaL) to form a complete LPS59. Since our previous results suggested that Cc5 
CPS is not linked to lipid A, we thought to generate a rough LOS strain, lacking the O-antigen but still harboring 
the CPS, by deleting the O-antigen ligase WaaL. We thus first searched for a WaaL homolog in Cc5 and found 
that the protein encoded by locus Ccan_15430 has sequence similarity to known WaaL sequences. As anticipated, 
deletion of Ccan_15430 determined the loss of wt LOS and the formation of a low molecular weight band likely 
representing the lipid A-core or rough LOS (Fig. 4a and b) thus suggesting that the mutated gene encodes for the 
O-antigen ligase WaaL of C. canimorsus. As expected, a normal capsular polysaccharide could be detected in the 
waaL mutant indicating that the absence of the O-antigen ligase affects only the LOS synthesis without interfer-
ing with the CPS assembly (Fig. 4a and b) and so reinforcing the evidence that Cc5 CPS is not linked to the lipid 
A-core. How the Cc5 CPS is linked to the bacterial surface was not investigated in detail and thus the presence of 
another lipid moiety anchoring the CPS to the bacterial surface could not be excluded. By deleting WaaL we thus 
obtained an encapsulated C. canimorsus harboring a rough LOS, lacking the O-chain.
We then aimed at generating a non-capsulated C. canimorsus strain, still endowed with its normal LOS (band 
C and C#). So far, our data indicated that Cc5 capsular polysaccharide is a group I (Wzy-dependent) CPS. The 
characteristic of the group I CPS assembled by a Wzy-dependent pathway is that single repeating units are syn-
thesized and exported to the periplasm where the Wzy polymerase assembles them forming the CPS. The CPS 
assembly is controlled by the activities of the Wzc and Wzb proteins and the transport of the CPS to the bac-
terial surface occurs thanks to a lipoprotein named Wza that forms a multimeric translocation channel in the 
outer membrane33. Since deletion of Wza generally abolishes capsule translocation at the bacterial surface46, we 
searched in Cc5 genome for a homolog of wza. The protein encoded by gene Ccan_15550 has 22% identity with 
the E. coli Wza protein. Deletion of Ccan_15550 turned out to be polar on the downstream Ccan_15540, a wzz 
homolog, which regulates the length of the LPS O-chain33,60. We thus investigated the role of Wzz (Ccan_15540) 
and found that, unlike what happens in E. coli, in C canimorsus, it would control the length of the CPS rather than 
the LOS (Supplementary Data S3 and Supplementary Fig. S3).
Thus, since deletion of wza had a polar effect on wzz, in order to generate a non-capsulated C. canimorsus strain 
endowed with normal LOS, we expressed in trans the cloned wzz gene in the wza mutant and analyzed the LOS and 
CPS profiles. As shown in Fig. 4c, expression of wzz in the wza deletion strain restored the normal LOS profile but 
not the CPS indicating that C. canimorsus CPS is transported by the Wza protein. Finally, the wza mutant express-
ing wzz in trans turned out to be the required non-capsulated C. canimorsus strain that harbors normal LOS.
Figure 3. Cc5 O-antigen and capsule monosaccharide composition. GC-MS monosaccharide profiles of the 
CPS (a) and LOS O-antigen (b) preparations of wt Cc5. *non-sugar impurities.
www.nature.com/scientificreports/
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The capsular polysaccharide contributes to survival in human serum, resistance to antimicro-
bial peptides and phagocytosis. In order to clarify the contribution of the LOS and the CPS in conferring 
resistance to the bactericidal activity of human serum, we compared the survival of wt and mutant bacteria 
lacking either the LOS O-antigen (Δ waaL), the CPS (Δ wza, wzz+) or both structures (Y1C12) in 10% human 
serum. As shown in Fig. 5a, the lack of the CPS only (Δ wza, wzz+) or of both CPS and LOS (Y1C12) determined 
a reduction of around 2.5 logs of the bacterial number thus suggesting a main role of the CPS in protecting against 
the bactericidal effect of human serum. Furthermore, encapsulated bacteria having a rough LOS (Δ waaL) were 
found to be as resistant as the wt strain thus indicating that the capsule alone is sufficient to confer resistance to 
human serum.
In order to determine the role of LOS O-antigen and CPS in resistance to phagocytosis, we then compared 
the same strains for phagocytosis by murine J774A.1 macrophages as determined by flow cytometry. With this 
method we assessed the mean fluorescence intensity (MFI) of macrophages incubated with fluorescently labeled 
bacteria. As shown in Fig. 5b, the lack of CPS (Δ wza, wzz+) or of both CPS and LOS resulted in an increase of 
about 2 fold of the MFI suggesting a main role of this structure in protecting against phagocytosis. In contrast, 
encapsulated bacteria lacking the LOS O-antigen (Δ waaL) were phagocytozed to the same extent as the wt strain 
thus excluding a main contribution of the LOS O-chain in preventing phagocytosis by macrophages (Fig. 5b).
Furthermore, we found that in the presence of Cytochalasin D, which inhibits phagocytosis61, the amount 
of bacteria associated to the macrophages was not identical for all strains tested. In particular, we observed 
an increase of 3 to 4 fold of the mean fluorescent intensity (MFI) of macrophages that were incubated with 
non-capsulated bacteria (Δ wza, wzz+) as compared to that of macrophages that were incubated with wt and 
waaL mutant bacteria (Fig. 5b). Since phagocytosis was inhibited, an increased MFI means a higher number of 
bacteria associated to the macrophage surface. It thus seems that bacteria lacking the CPS adhere more to the 
macrophages, which then might lead to an increased phagocytosis.
Overall these data indicate that C. canimorsus CPS could confer protection from phagocytosis by reducing 
bacterial adhesion to the macrophages.
Capsular polysaccharides have also been shown to play a role in protecting bacteria against antimicrobial pep-
tides and proteins that are part of the innate immune response against bacteria62. Recently we showed that Cc5 
bacteria are highly resistant to polymyxin B (MIC ≥ 1024 mg/L) (Fig. 5c and ref. 63). A main contribution to this 
property could be attributed to a specific feature of the lipid A moiety, which did neither affect the LOS O-antigen 
nor CPS expression63. In addition to the role of Cc5 lipid A modification we wondered whether the capsular 
polysaccharide and the LOS O-chain would contribute to protect bacteria against cationic antimicrobial peptides 
(CAMPs). We thus determined the resistance to polymyxin B of non-capsulated and rough LOS mutants. As 
shown in Fig. 5c, bacteria lacking the CPS only (Δ wza, wzz+) or both CPS and LOS (Y1C12) had a reduced MIC 
(≥ 512 mg/L) as compared to the wt (≥ 1024 mg/L). In contrast, encapsulated bacteria lacking the LOS O-antigen 
(Δ waaL) were found to be as resistant as the wt strain. These data thus indicate that the CPS structure is contrib-
uting to the protection against the bactericidal effect of polymyxin B and hence, likely of CAMPs.
Figure 4. Generation of rough LOS and non-capsulated Cc5. (a) Immunoblot analysis of proteinase 
K-treated Cc5 wt and waaL mutant using anti-Cc5 serum. (b) Immunoblot analysis using Y1C12-adsorbed 
anti-Cc5 serum of proteinase K-treated Cc5 waaL mutant complemented or not with waaL. (c) Immunoblot 
analysis using Y1C12-adsorbed anti-Cc5 serum of proteinase K-treated Cc5 wza mutant complemented or not 
with wzz, wza or wza and wzz. (d) Genetic organization of the wza-wzz gene cluster.
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In conclusion, our data indicate that the capsular polysaccharide of Cc5 likely contributes to the pathogenesis 
by providing protection against the bactericidal effect of human serum, antimicrobial peptides and phagocytosis 
by innate immune cells.
Opsonization with anti-LOS O-antigen and capsule antibodies enhances killing in human 
serum. Opsonization plays a major role for effective killing of bacterial pathogens by human serum. We thus 
tested whether opsonization with the anti-LOS O-chain and capsule specific antibodies from the Y1C12-adsorbed 
antiserum would increase the bactericidal effect of human serum on C. canimorsus. As shown in Fig. 5d, in the 
presence of Y1C12-adsorbed antiserum the bactericidal effect of human serum on wt C. canimorsus was signifi-
cantly increased (around 10 times) if compared to bacteria incubated in the human serum only. Taken together 
these data suggest that opsonization with LOS O-chain and capsule specific antibodies reduces the survival of 
C. canimorsus in human serum and thus indicate that these antibodies could have a potential protective role for 
the human host by increasing the ability of the innate immune system to clear the bacterial infection at its onset.
A capsular polysaccharide is likely a commonality in C. canimorsus. The finding of a capsular poly-
saccharide in Cc5 and its likely role in resistance to the innate immunity raises the question whether other strains 
of C. canimorsus would be endowed with a similar structure at their surface.
We first investigated the three C. canimorsus draft genomes available to date, namely C. canimorsus 2 (Cc2), 
C. canimorsus 11 (Cc11) and the C. canimorsus type strain ATCC35979 (Cc12)64. The three genomes contain 
wza and wzz orthologs organized in a two gene operon (Fig. 6a) suggesting the presence of a capsule in all 
these strains. As shown in Fig. 6a, we could also identify in all three genomes clusters of genes likely involved in 
LOS/CPS biosynthesis. However, while Cc2 and Cc11 encode orthologs for most of the Cc5 genes (Fig. 6a and 
Figure 5. The capsule protects Cc5 against serum and polymyxin B killing and phagocytosis. (a) Total 
bacterial CFU present after incubation with 10% heat inactivated human serum (HIHS) or 10% normal human 
serum (NHS) for 1 hour at 37 °C. Mean values from 3 different experiments and standard deviations are 
represented (***p ≤ 0.001 compared to wt). (b) Phagocytosis of Cc5 bacteria by J774A.1 macrophages. J774A.1 
macrophages were incubated with eFluor® -stained bacteria and subsequently analyzed by FACS. Cytochalasin 
D (CytD) pretreatment of macrophages was performed to inhibit phagocytosis. Mean values from 3 different 
experiments and standard deviations are represented (***p ≤ 0.001, **p ≤ 0.01 compared to wt). ni = non-
infected macrophages. (c) Role of capsular polysaccharide on polymyxin B resistance. MIC of Polymyxin B for 
Cc5 wt, Y1C12, waaL (rough LOS), and Δ wza (wzz+) (non-capsulated) bacteria. Data were combined from 
3 independent experiments where measured MIC were identical. (d) Effect of opsonization on serum killing. 
Total bacterial CFU of wt Cc5 present after incubation with HIHS or NHS and NHS in the presence of heat 
inactivated normal rabbit serum (NHS + NRS) or heat inactivated anti-Cc5 Y1C12–adsorbed rabbit serum 
(NHS + Y-ads). Mean values from 3 different experiments and standard deviations are represented (**p ≤ 0.01 
compared to NHS).
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Supplementary Table S3), albeit organized in several clusters distributed throughout the genomes, Cc12 showed 
a unique gene cluster but highly divergent from the Cc5 one in terms of composition (Fig. 6a). Then, we tested 
Cc2, Cc11 and Cc12 with the Cc5 LOS/CPS specific antiserum, As shown in Fig. 6b, the CPS and LOS from Cc2 
were recognized suggesting that the O-antigen and capsule of Cc2 and Cc5 could have common epitopes. In 
contrast, the CPS and LOS from Cc11 and Cc12 were not recognized and hence could be substantially differ-
ent from the Cc5 one, which was somehow expected for Cc12 given the low conservation of the LOS/CPS loci 
(Fig. 6a) but more surprising for Cc11. However, the Cc11 genome does not encode the ortholog of Ccan_23210 
(Fig. 6a and Supplementary Table S3), a glycosyltransferase, shown to be crucial for Cc5 LOS and CPS biosyn-
thesis (Supplementary Data S1 and Supplementary Fig. S2). Finally, in order to see if the presence of a CPS is a 
common feature of the C. canimorsus species, we analysed the polysaccharides of nine strains, including Cc2, 
Cc11 and Cc12, by SDS-PAGE followed by alcian blue and silver staining. As shown in Fig. 6c, all tested strains 
exhibited a capsular-like polysaccharide. In conclusion, the CPS is very likely a common feature of C. canimorsus 
but its composition and/or structure could vary between strains.
Discussion
Here we present the first evidence of a capsular polysaccharide at the surface of the emerging human pathogen 
C. canimorsus. Although most of the work was done with strain Cc5, we show that the presence of a capsule is 
most likely a commonality in C. canimorsus. We provide genetic and analytical data showing that the CPS and 
LOS O-antigen repeating units share similar monosaccharides and epitopes. In the genome of strain Cc5, the 
genes encoding the O-chain and CPS repeating units biosynthesis, assembly and transport are grouped in a 27 kb 
cluster. This cluster includes the genes coding for the synthesis of UDP-GalA (ugd and uge), FucNAc (fnlA, fnlB, 
fnlC) and QuiNAc (wbtA and wbtB). In agreement with the genetic annotation we identified by GC-MS analysis 
as constituents of the Cc5 CPS and O-antigen units: QuiN, FucN, Glc, Gal, GalN and uronic acid. In addition, 
homologs of genes found in the O-antigen clusters of several E. coli serotypes as wfdP, wfdQ and wfdR65 are 
also present in the Cc5 O-antigen cluster. The cluster includes also genes involved in the synthesis of rhamnose 
(rmlA, rmlC and rmlD) that was previously shown to be part of the Cc5 core oligosaccharide49. Several putative 
glycosyltransferase genes are also present in the locus, including wbuB encoding a FucNAc transferase as well 
as Ccan_23210 and Ccan_23290 found to be crucial for the O-chain and CPS synthesis. Deletion of the genes 
involved in the synthesis or transfer of QuiNAc, FucNAc and GalA led to LOS O-chain modification and lack 
of CPS thus confirming that both O-antigen and CPS contain these monosaccharides or derivatives thereof and 
therefore likely share identical residues. Regarding O-units transport and assembly, the cluster encodes the Wzx 
flippase and the Wzy polymerase. By deleting the Wzx and Wzy homologs we could show that Cc5 harbors a LOS 
and that the CPS only is assembled by the Wzy polymerase.
Figure 6. A capsular polysaccharide is present in several C. canimorsus isolates. (a) Comparison of the LOS/
CPS-biosynthesis and transport loci of the four sequenced C. canimorsus strains. The boxes indicate different 
genomic loci. Orthologs of the Cc5 genes are indicated in grey. Genes indicated in white are strain specific 
genes likely involved in LOS/CPS biosynthesis. The hatched pattern indicates genes likely unrelated to LOS/CPS 
biosynthesis and transport. Fragmented genes are marked with (f). Note that the genomes of Cc2, Cc11 and 
Cc12 are draft genomes. For the sake of simplicity genes are not represented to scale. (b) Immunoblot analysis of 
proteinase K-treated Cc5, Cc2, Cc11 and Cc12 using Y1C12-adsorbed anti-Cc5 serum. (c) Alcian blue staining 
before (left) and after silver staining (right) of proteinase K-resistant structures of several C. canimorsus strains 
showing the presence of a capsular polysaccharide (CPS).
www.nature.com/scientificreports/
9Scientific RepoRts | 6:38914 | DOI: 10.1038/srep38914
Capsular polysaccharides play a role in the pathogenicity of several bacteria. In particular, in the phylum 
Bacteroidetes the presence of a capsule has been linked to the virulence of the human pathogens Bacteroides 
fragilis and Porphyromonas gingivalis. In B. fragilis several capsular polysaccharides have been identified and char-
acterized66 and their role in pathogenicity has been linked to the ability of capsulated bacteria to induce abscess 
formation in animals67 and the capsule has been shown to mediate resistance to complement-mediated killing 
and to phagocytosis68. Interestingly, while in the genome of Bacteroides fragilis NCTC 9343 ten loci have been pre-
dicted to be implicated in polysaccharide biosynthesis, each including putative Wzx and Wzy homologs69, in the 
genome of four strains of C. canimorsus51,64 we could, so far, identify only one locus encoding the genes involved 
in both O-chain and CPS biosynthesis. Furthermore, B. fragilis are endowed with a so called micro-capsule (MC) 
(around 35 nm in size) whose variable expression is controlled by genes that are switched on and off by the 
site-specific inversion of promoter sequences70–72. Such sequences could not be found in the genome of Cc551 
either, suggesting that CPS expression is regulated differently in the two species. In addition, B. fragilis harbor 
antigenically distinct and within-strain variable large capsules (LCs) and small capsules (SCs)52,73. In contrast in 
C. canimorsus, electron microscopy observation revealed the presence of a 50 nm in size CPS that was completely 
absent in the O-unit biosynthesis mutant thus suggesting that C. canimorsus harbors only one CPS type, related 
to the LOS O-antigen.
In P. gingivalis the capsule has been shown to be a major virulence factor in a mouse abscess model and to 
play a role in decreasing the host inflammatory response and phagocytosis74. In our previous work we showed 
that Cc5 is resistant to the bactericidal effect of 10% human serum and is able to escape phagocytosis13. Here we 
show that the presence of the CPS increases Cc5 survival in human serum, resistance to CAMPs and reduces the 
uptake by macrophages. We found this latter effect to be a consequence of increased adhesion of bacteria lacking 
the CPS to macrophages thus suggesting that the CPS reduces the ability of C. canimorsus to adhere to host cells. 
Unfortunately, to date, no reliable animal model exists for C. canimorsus infections and thus the role of the CPS 
in vivo could not be determined. Nevertheless our in vitro results clearly suggest that the CPS could play a major 
role in C. canimorsus infections probably at their onset conferring protection against the bactericidal effect of 
serum and phagocytosis. Furthermore, we could show that antibodies targeting the O-chain and the CPS increase 
the killing of Cc5 in human serum thus suggesting a potential protective role for the host against these tremen-
dous bacterial infections.
Materials and Methods
Bacterial strains and growth conditions. Bacterial strains used in this study are listed in 
Supplementary Table S1. C. canimorsus were routinely grown on heart infusion agar (Difco) supplemented with 5% 
sheep blood (Oxoid) plates (SB plates) for 2 days at 37 °C in the presence of 5% CO2. E. coli strains were routinely 
grown in lysogeny broth (LB) at 37 °C. As selective agents, antibiotics were added at the following concentrations: 
100 μ g/ml ampicillin (Amp), 50 μ g/ml kanamycin (Km) for E. coli and 10 μ g/ml erythromycin (Em), 10 μ g/ml 
cefoxitin (Cfx), 20 μ g/ml gentamicin (Gm), 10 μ g/ml tetracycline (Tc) for C. canimorsus.
C. canimorsus 5 and Y1C12-adsorbed antisera. Polyclonal serum against C. canimorsus 5 was generated 
from a rabbit by immunization with paraformaldehyde fixed C. canimorsus 5 (Animal facility of the University 
of Namur). The Y1C12-absorbed serum was prepared by incubating three times an excess amount of paraform-
aldehyde fixed Y1C12 mutant bacteria harvested from SB plates and washed in phosphate-buffered saline (PBS) 
with anti-C. canimorsus 5 serum at 4 °C for minimum 4 hours. Bacteria were removed by repeated centrifugation.
Immunoblotting of proteinase K-resistant structures. Bacteria grown for 2 days at 37 °C with 5% CO2 
were harvested from SB plates, washed once in 1 ml of PBS and adjusted to an OD600 of 1 in PBS. 750 μ l bacterial 
suspension was pelleted and resuspended in 125 μ l ddH2O loading buffer (1% sodium dodecyl sulfate [SDS], 10% 
glycerol, 50 mM dithiothreitol, 0.02% bromophenol blue, 45 mM Tris (pH 6.8)). Samples were heated at 99 °C for 
10 minutes. Proteinase K (50 μ g/ml final concentration) was added and samples were incubated at 37 °C over-
night. After incubation samples were heated again for 10 minutes at 99 °C and a second volume of proteinase K 
(equal to the first) was added. Samples were incubated at 55 °C for 3 hours, heated again for 5 minutes at 99 °C and 
loaded on a 15% SDS-PAGE. Samples were analyzed by western blotting.
In vivo radiolabeling with [3H] palmitate and fluorography. Bacteria grown for 2 days on SB plates were 
collected and resuspended in PBS to an OD600 of 0.1. Six μ l of bacterial suspension (approx. 3 × 105 bacteria) were 
seeded in 3 ml of DMEM (41965-039; Gibco) containing 10% heat-inactivated human serum (HIHS) in 12-well 
plates (665 180; Greiner Bio-one). After 18 h of incubation at 37 °C with 5% CO2, [9,10-3H] palmitic acid (32 Ci/
mmol; NET043; Perkin-Elmer Life Sciences) was added to a final concentration of 50 μ Ci/ml and incubation was 
continued for 6 h. Bacteria were then collected by centrifugation, washed 2 times with 1 ml PBS and pellets were 
stored at − 20 °C until further use. Pellets were treated with proteinase K as described above. Samples were loaded 
on 12% SDS PAGE gels and after electrophoresis, gels were fixed in 25:65:10 isopropanol:water:acetic acid solution 
overnight and subsequently soaked for 30 min in Amplify (NAMP100; Amersham) solution. Gels were vacuum 
dried and exposed to SuperRX autoradiography film (Fuji) for 12–18 hours until desired signal strength was reached.
Gene annotation and LOS/CPS loci analysis. BlastP75 and Delta Blast searches were carried out against 
the C. canimorsus 5 genome51. Query sequences were obtained from the NCBI database. All available search 
sequences for a corresponding gene of interest were used. The highest scoring subjects over all the searches have 
been annotated as corresponding enzymes. Analysis of synteny of the LOS/CPS C. canimorsus loci was obtained 
from the MicroScope Microbial Genome Annotation and Analysis Platform (https://www.genoscope.cns.fr/agc/ 
microscope/home/index.php)76. Putative orthologous relations between two genomes are defined as gene cou-
ples satisfying the bi-directional best hit (BBH) criterion or a BlastP alignment threshold, a minimum of 35% 
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sequence identity on 80% of the length of the smallest protein. These relations are subsequently used to search 
for conserved gene clusters, synteny groups (syntons), among several bacterial genomes. All possible kinds of 
chromosomal rearrangements are allowed (inversion, insertion/deletion).
Mutagenesis and allelic exchange. Genetic manipulations of C. canimorsus 5 wt have been previously 
described77. Briefly, replacement cassettes with flanking regions spanning approximately 500 bp homologous to 
direct target gene framing regions were constructed with a three-fragment overlapping-PCR strategy. First, two 
PCR were performed on 100 ng of Cc5 genomic DNA with primers A and B (Supplementary Table S2) for the 
upstream flanking regions and with primers E and F for the downstream regions. Primers B and E contained an 
additional 5′ 20-nucleotide extension homologous to the ermF or tetQ insertion cassettes. The ermF and tetQ 
resistance cassettes were amplified from plasmids pMM13 and pMM104.A77 DNA respectively with primers C 
and D. All three PCR products were cleaned and then mixed in equal amounts for PCR using Phusion polymer-
ase (Finnzymes). The initial denaturation was at 98 °C for 2 min, followed by 12 cycles without primers to allow 
annealing and elongation of the overlapping fragments (98 °C for 30 s, 50 °C for 40 s, and 72 °C for 2 min). After 
the addition of external primers (A and F), the program was continued with 20 cycles (98 °C for 30 s, 50 °C for 
40 s, and 72 °C for 2 min 30 s) and finally 10 min at 72 °C. Final PCR products were then digested with PstI and 
SpeI for cloning into the appropriate sites of the C. canimorsus suicide vector pMM2577. Resulting plasmids were 
transferred by RP4-mediated conjugative DNA transfer from E. coli S17-1 to C. canimorsus 5 to allow integration 
of the insertion cassette. Transconjugants were then selected for the presence of the ermF or tetQ resistance cas-
settes on erythromycin and tetracycline plates respectively and checked for sensitivity to cefoxitin. Deletion of the 
appropriate regions was verified by PCR.
Construction of plasmids for trans-complementation. Full length C. canimorsus 5 genes: Ccan_23200 
(wzx), Ccan_23280 (wzy), Ccan_15430 (waaL), Ccan_23190 (uge), Ccan_23400 (wbtA), Ccan_15540 (wzz), 
Ccan_15550 (wza), Ccan_23210 and Ccan_23290, were amplified from C. canimorsus 5 genomic DNA using 
primers listed in Supplementary Table S2 and cloned into plasmid pPM578 into NcoI and XhoI restriction sites 
leading to plasmids listed in Supplementary Table S1. Gene couples Ccan_15540–15550, Ccan_23200–23210 and 
Ccan_23280–23290 were co-amplified from C. canimorsus 5 genomic DNA and cloned into plasmid pPM578 into 
NcoI and XhoI restriction sites.
Human serum sensitivity assay. Bacteria were harvested by gently scraping colonies off the agar surface. 
They were washed and resuspended in PBS to an OD600 of 1. Normal human serum (NHS) from healthy volun-
teers was pooled, aliquoted, and stored at − 80 °C. Serum was heat inactivated (HIHS) at 55 °C for 30 min when 
indicated. A total of around 1 × 107 bacteria were incubated for 1 or 3 hours in 200 μ l 10% NHS or HIHS in PBS 
(around 5 × 107 bacteria/ml) at 37 °C with 5% CO2. Serial dilutions were plated onto SB plates, and viable colonies 
were counted after 48 hours of incubation. To test the impact of anti-LOS and capsule antibodies on the survival 
of C. canimorsus 5, wt bacteria were treated as described above (1 hour incubation) with the exception that heat 
inactivated Y1C12-adsorbed anti Cc5 serum (1/200 dilution) or heat inactivated normal rabbit serum (1/200 
dilution) were added to the bacterial suspensions before incubation.
Polymyxin B sensitivity assay. Polymyxin B sulphate was obtained from Sigma-Aldrich. The agar dilution 
method was performed based on the CLSI/NCCLS recommendations79. Briefly, 104 bacteria diluted in PBS were 
spotted in 2 μ l on SB plates containing Polymyxin B ranging from 0.5 mg/L to 1024 mg/L (2-fold increase per 
condition). Plates were examined for growth of colonies after 48 hours and 72 hours.
Phagocytosis assay by flow cytometry. Murine J774A.1 (ATCC TIB-67) macrophages were cultivated 
in RPMI 1640 (Gibco) medium supplemented with 2 mM glutamine (Gibco) and 10% fetal bovine serum (Gibco). 
For phagocytosis assay macrophages were seeded overnight in 24 well plates (1 × 105 cells/well) at 37 °C and 5% 
CO2. To inhibit phagocytosis macrophages were treated prior to infection for 30 min with 10 μ M cytochalasin D 
(Sigma Aldrich). Bacteria (OD600 of 1) were stained with eFLuor® 670 (eBioscience) at a concentration of 5 μ M 
for 15 min at 37 °C in PBS then washed 3 times in PBS. Macrophages were infected at a MOI of 10 with labeled 
bacteria, spun (400 × g, 5 min) and incubated for 1 h at 37 °C and 5% CO2. Macrophages were then washed with 
PBS, scraped and washed again 2 more times with PBS before being fixed for 15 min in 4% PFA (Sigma Aldrich). 
Macrophages were then analyzed by FACS on a FACSCalibur using Cell quest Pro (BD Bioscience).
Statistical analysis. Statistical analyses were realized using the software GraphPad Prism by one-way 
ANOVA test followed by a Bonferroni test.
LOS isolation. C. canimorsus were harvested from 600 SB plates in PBS and washed with ddH2O, ethanol 
(300 ml) and acetone (300 ml), followed each time by centrifugation at 18000 × g for 30 min. LOS used for western 
blot analysis was isolated from C. canimorsus 5 wt and Y1C12 mutant as described in ref. 36.
Alcian blue and silver staining of proteinase K-resistant structures. Bacteria treated with protein-
ase K as described above were loaded on 15% Tris-glycine SDS polyacrylamide gels. Following electrophoresis, 
the gels were stained first with Alcian blue (Sigma) (0.125% Alcian blue in 40% ethanol–5% acetic acid) and then 
with silver as described in ref. 80.
Preparation of the CPS and O-antigen for composition analysis. C. canimorsus were harvested from 
25 SB plates in PBS with 1% phenol and washed twice with ddH2O. The isolation of LOS was achieved after 
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phenol-water extraction57 with or without phase separation. The lyophilized extracts were analyzed by western 
blot using full and Y1C12-adsorbed anti-Cc5 serum before performing chemical modifications and carbohy-
drate analysis. Crude extracts were hydrolyzed with 5% AcOH (100 °C, 2 hours), cooled, lyophilized, resuspended 
in 2 ml of water, centrifuged and fractionated on a Sephadex S-300 column. LMW fractions were pooled and 
re-fractionated on a Biogel P2 column.
General and analytical methods. Gel filtration chromatography was performed on a Sephacryl S-300 
column (Pharmacia, 1 × 80 cm) and a Bio-Gel P2 column (1.6 × 80 cm) eluted with 0.1% acetic acid. Aliquots 
of each fraction were assayed for neutral sugars81. Monosaccharides were identified by GC-MS with a Trace GC 
ULTRA system (Thermo Scientific) equipped with an NMTR-5MS capillary column (30 m × 0.25 mm) with a 
temperature gradient of 170 °C (3 min) to 250 °C at 5 °C min−1 and with a DSQ II MS detector. Prior to analysis, 
carbohydrate samples were hydrolyzed with 4 M trifluoroacetic acid (110 °C, 3 h) and converted to alditol acetates 
by conventional methods. For the identification of QuiNAc and FucNAc, authentic standards of P. aeruginosa 
PA14 and PAO1 O-antigens were used.
Transmission electron microscopy (TEM). Thin sectioning. Bacteria were harvested from SB plates and 
resuspended in PBS to an OD600 of 1 (corresponding to 5 × 108 bacteria/ml). Around 3 × 105 bacteria were seeded 
in 1 ml of DMEM (41965-039; Gibco) containing 10% heat-inactivated human serum (HIHS) in 12-well plates 
(665 180; Greiner Bio-one) and incubated 23 hours at 37 °C with 5% CO2. 7 ml of Cc5 wt and Y1C12 cultures were 
centrifuged 5 min at 5000 g and washed with 10 ml PBS. Bacteria were then centrifuged and resuspended in 5 ml 
PBS containing 2% glutaraldehyde. Bacteria were then fixed in Karnofski solution (3% paraformaldehyde, 0.5% 
glutaraldehyde in 10 mM PBS, pH 7.4) for 1 hour, washed once in PBS and post-fixed first in 1% reduced osmium 
tetroxide (containing 1.5% potassium ferricyanide) for 40 minutes and subsequently in 1% osmium tetroxide for 
another 40 minutes. After washing in water, fixed samples were dehydrated, embedded in Epon resin, and pro-
cessed for TEM as described82. EM micrographs were recorded on CCD camera using a Morgani transmission 
electron microscope (FEI, The Netherlands) operating at an acceleration voltage of 80 kV.
Cryo-transmission electron microscopy (Cryo-TEM) analysis. 4 μ l of bacteria resuspended in a PBS 2% glut-
araldehyde solution were adsorbed onto glow-discharged holey carbon-coated grid (quantifoil, Germany) 
plunge-frozen into liquid ethane at − 178 °C using a Leica EM GP machine (Leica Microsystems, Austria). Frozen 
grids were transferred onto a Philips CM200-FEG electron microscope using a Gatan 626 cryo-holder. Electron 
micrographs were recorded at an accelerating voltage of 200 kV and a nominal magnification of 50,000x, using a 
low-dose system (10 e-/Å2) and keeping the sample at − 175 °C. Defocus values were − 3 μ m. Micrographs were 
recorded at 4 K × 4 K CMOS camera (TVIPS, Germany).
Ethics statement. This study was approved by the Comité d’éthique médicale from the CHU Mont-Godinne/
Université de Louvain (no: B039201316262) and experiments carried out according to the declaration of Helsinki 
and the Belgian law on experiments in humans from March 7th, 2004. Human blood was collected from healthy 
volunteers who were informed about the aim of the study and the risks of blood withdrawal and had signed a 
written informed consent. The animal handling and procedures used in this study were approved by the Animal 
Welfare Committee of the University of Namur (no: FUNDP LE 08/106).
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